Mus vs Sao Tome and Principe: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Mus
100.0%
in 2014
Sao Tome and Principe
100.0%
in 2014
Mus rank
1st
Sao Tome and Principe rank
1st
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Mus
- Sao Tome and Principe
How they compare
Mus currently reports 100.0% against 100.0% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 3 times across 9 shared years of data; in 2006 it was Mus ahead.
Mus ranks 1st and Sao Tome and Principe ranks 1st of 2 regions.
Mus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mus | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 82.5% | 75.0% | 7.5% | Mus |
| 2010s | 100.0% | 98.4% | 1.6% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Mus or Sao Tome and Principe?
- Mus, at 100.0% against 100.0% in Sao Tome and Principe as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Mus and Sao Tome and Principe?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Sao Tome and Principe?
- 9 years are reported by both, from 2006 to 2014.
- How do Mus and Sao Tome and Principe rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Mus ranks 1st and Sao Tome and Principe ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.